Amalgamated Bank Has $1.18 Million Holdings in Sotera Health (NASDAQ:SHC)

Amalgamated Bank raised its stake in Sotera Health (NASDAQ:SHC) by 10.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 70,347 shares of the company’s stock after buying an additional 6,911 shares during the quarter. Amalgamated Bank’s holdings in Sotera Health were worth $1,175,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. William Blair Investment Management LLC raised its position in shares of Sotera Health by 0.6% in the 2nd quarter. William Blair Investment Management LLC now owns 1,131,455 shares of the company’s stock valued at $13,430,000 after acquiring an additional 6,707 shares during the period. Clearline Capital LP bought a new stake in Sotera Health in the second quarter valued at approximately $1,707,000. First Pacific Advisors LP acquired a new stake in Sotera Health in the second quarter worth $540,000. Darsana Capital Partners LP bought a new position in shares of Sotera Health during the second quarter worth $29,074,000. Finally, Bank of New York Mellon Corp grew its holdings in shares of Sotera Health by 3.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,004,046 shares of the company’s stock valued at $11,918,000 after buying an additional 37,681 shares during the period. Institutional investors own 91.03% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently commented on SHC shares. Citigroup raised their price objective on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, November 6th. Barclays lifted their price objective on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a research note on Tuesday, August 6th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $16.50.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $15.32 on Thursday. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The firm has a market cap of $4.34 billion, a price-to-earnings ratio of 61.28 and a beta of 2.08. The stock’s 50-day moving average is $16.00 and its 200-day moving average is $13.83. Sotera Health has a one year low of $10.71 and a one year high of $17.44.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). The firm had revenue of $285.47 million during the quarter, compared to the consensus estimate of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company’s revenue was up 8.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.18 EPS. Equities analysts predict that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction on Friday, September 6th. The shares were sold at an average price of $15.03, for a total value of $150,300,000.00. Following the sale, the director now directly owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 55.12% of the stock is currently owned by corporate insiders.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.